| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| SG&A Expense | $11.0M | — | +22.2% |
| Net Income | -$148.0M | — | -396.0% |
| EPS (Basic) | -$0.17 | — | -950.0% |
| EPS (Diluted) | -$0.17 | — | -950.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $493.0M | +9.6% | +8.4% |
| Total Assets | $118.90B | +3.3% | +24.0% |
| Total Liabilities | $106.72B | +3.9% | +24.3% |
| Stockholders' Equity | $12.18B | -1.7% | +21.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $387.0M | — | +101.6% |
| Investing Cash Flow | -$2.00B | — | +65.2% |
| Financing Cash Flow | $2.22B | — | -59.4% |